Abstract:Objective To analyze plasma level of catestatin and its clinical significance in patients with different types of atrial fibrillation. Methods A total of 84 consecutive patients with atrial fibrillation were enrolled in this study. Atrial fibrillation was categorized as paroxysmal atrial fibrillation(n = 61) and chronic atrial fibrillation (n = 23). Another 46 patients matched for concomitant diseases in sinus rhythm without any atrial fibrillation history consisted of control group. Medical history, physical examination, laboratory parameters and echocardiography were recorded. Plasma levels of catestatin were measured by ELISA and compared between groups. Results Plasma catestatin levels were decreased in overall atrial fibrillation group than in control group [0. 54 (0. 34 - 0. 96) mg/ L vs. 0. 87 (0. 59 - 1. 31) mg/ L, Z =- 3. 491, P < 0. 001]. In subgroup analysis, compared with the control group, plasma catestatin levels were significantly decreased in both paroxysmal atrial fibrillation [0. 58(0. 36 - 0. 98) mg/ L, Z = - 2. 807, P =0. 005] and chronic atrial fibrillation [0. 43 (0. 27 - 0. 78) mg/ L, Z = - 3. 450, P < 0. 001] groups. Compared with paroxysmal atrial fibrillation group, plasma catestatin levels were decreased in chronic atrial fibrillation group, although it was not statistically significant (Z = - 1. 495, P = 0. 136). Plasma catestatin levels of the patients in atrial fibrillation and in sinus rhythm at the time of catestatin sampling were similar (Z = - 0. 028, P = 0. 980), but both decreased than in the control group [0. 59(0. 33 - 0. 92) mg/ L, Z =- 3. 091, P = 0. 002; 0. 51 (0. 34 - 1. 00) mg/ L, Z = - 2. 859, P = 0. 004] . Multivariate logistic regression analysis showed that lower CST level ( OR = 0. 631, P = 0. 049 ) and elevated NT-proBNP ( > 125 ng/ L) (OR = 12. 416,P < 0. 001) were the independent predictors of atrial fibrillation. Using a receiver operating characteristic curve, the optimal cut-off value for plasma CST was 0. 73 mg/ L in the diagnosis of paroxysmal atrial fibrillation with 60. 9% sensitivity and 63. 9% specificity, the area under the curve( AUC) was 0. 659 ( P = 0. 005) . Conclusions Plasma catestatin levels of patients with atrial fibrillation are significantly decreased. Lower catestatin level may be the independent factor associated with atrial fibrillation incidence.

The Plasma Level of Aldsterone and the Tissue Expression of Mrna of Aldosterone-Synthase in Patients with or Without Tatrial Fibrillation

Activation of Extracellular-Signal Regulated Kinase and Protein Phosphatases in Human Atria During Atrial Fibrillation

Expression of Mrna of CYP11B2 in Patients with and Without Atrial Fibrillation

Changes of Protein Expression of Connexin 40, 43 in Human Atrial Fibrillation

E0356 the Research on Calcium Homeostasis Expression and Gene Transcription of Atrial Myocytes in Patients with Atrial Fibrillation

[Expression of Connexin in Atrium of Patients with Atrial Fibrillation and Its Signal Transduction Pathway].

[Effects of Angiotensin Converting Enzyme Inhibitor on the Expression of Angiotensin Converting Enzyme 2 in Atrium of Patients with Atrial Fibrillation].

Possible involvement of fibrocytes in atrial fibrosis in patients with chronic atrial fibrillation.

Study of chloride channel ClC-3 gene expression in patient with atrial fibrillation

Increased Expression of Mineralocorticoid Receptor in Human Atrial Fibrillation and a Cellular Model of Atrial Fibrillation

The Alteration of Connexin 40 Distribution and Expression in Right Atrial Myocardium in Patients with Different Types of Atrial Fibrillation

Changes of the mRNA and Protein Expression of T-type Calcium Channels in PVA of Human with Chronic Atrial Fibrillation

Reduced Testosterone Levels in Males with Lone Atrial Fibrillation

Plasma levels of hs-CRP and IL-6 in patients with different types of atrial fibrillation

Proteomic Analysis Of Atrial Appendages Revealed The Pathophysiological Changes Of Atrial Fibrillation

Expression of Matrix Metalloproteinase and Cytokines During Atrial Fibrillation Investigation

Association between inflammatory response and early recurrence of atrial fibrillation after catheter ablation

Plasma Level of Catestatin in Patients with Different Types of Atrial Fibrillation

Proteomic profiles of patients with atrial fibrillation provide candidate biomarkers for diagnosis

Association Of Plasma C1q/Tnf-Related Protein 3 (Ctrp3) In Patients With Atrial Fibrillation

Dysregulation of Circular RNAs in Atrial Appendages of Patients with Atrial Fibrillation